AboutMesothelioma.Net

Personalized Medicine, or theranostics, is the integration of therapeutics and diagnostics. This type of medicine follows the concept that a patient’s specific characteristics, such as height, weight, gender, and age, can be used to tailor medical care, as opposed to treating all patients the same.

Theranostics has moved pharmaceuticals further into the use of genetic testing to determine the correct treatment for a given disease. In the past large companies have dominated the market, but specialized companies are now beginning to play a role.

Rosetta Genomics is one such company involved in micro RNA testing. The company reported its first revenues recently, as well as demonstrating a two-fold decrease in liver cancer tumor-mass using their therapies. Another of their diagnostic tests, miRview(TM) meso, differentiates mesothelioma from other carcinomas in the lung.

With more and more companies entering the theranostics market, in the long run a lower cost of care should be realized by eliminating unnecessary and ineffective treatment.

To learn more about continued mesothelioma medical companies look through our website. You will find information including diagnosis, treatment, clinical trials, doctors and hospitals treating the disease, and your legal options.

Personalized Medicine